Serva Health Insights
Welcome to the Serva Health Blog—your destination for insights on patient engagement, clinical trial support, and biopharma commercial services. Our insights are designed to provide valuable information and expert perspectives on how to enhance patient care, streamline clinical trial processes, and navigate the complexities of healthcare. Here, you’ll find articles that explore the latest trends in patient support strategies, innovative healthcare technologies, and best practices for optimizing patient outcomes. Stay informed with Serva Health as we continue to shape the future of healthcare services.
Clinical trial recruitment is often measured by how many prospective participants enter the funnel. But high lead volume does not necessarily translate into enrollment. Clinical trial referral quality depends on whether prospective participants reach investigative sites with the information, preliminary eligibility checks, medical records, and expectations needed for the site
For many specialty therapies, receiving a prescription is only the beginning of the access journey. Patients may still need insurance coverage confirmed, prior authorization completed, out-of-pocket costs understood, financial support explored, and the prescription routed to the appropriate specialty pharmacy before treatment can begin. Specialty medications vary widely, but they
Digital health technologies in clinical trials can make it possible to collect meaningful data from participants outside the traditional research site. Wearables, mobile applications, connected sensors, electronic outcome assessments, and other tools can capture information where participants actually live, work, sleep, and move through their daily routines. That can make
A patient support program can only be as effective as the operating model behind it. Strong patient support program design starts before launch by identifying how patients, healthcare providers, payers, specialty pharmacies, and sites of care will move through the access and treatment journey. The goal is not simply to
Clinical trials are complex by design, but not every delay is caused by the science. Some of the most persistent clinical trial operational bottlenecks develop in the spaces between major milestones: a patient referral that needs additional information, an outreach call that goes unanswered, medical records that have not arrived,
Getting a prescription is not always the same as getting access to treatment. For patients prescribed specialty medications or other complex therapies, the path between a healthcare provider’s treatment decision and the start of therapy can include insurance verification, prior authorization, coverage restrictions, documentation requests, appeals, and questions about out-of-pocket